In vivo tracking techniques for cellular regeneration, replacement, and redirection

Journal of Nuclear Medicine

Volumn 53, Issue 12, 2012, Pages 1825-1828

  Aarntzen, Erik H J G ^a   Srinivas, Mangala ^a   Walczak, Piotr ^b   Janowski, Miroslaw ^b,c   Heerschap, Arend ^a   De Vries, I Jolanda M ^a   Figdor, Carl G ^a   Bulte, Jeff W M ^b   Oyen, Wim J G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Cellular therapy; In vivo imaging; Regenerative medicine; Tracking; Transplantation

Indexed keywords

3' FLUOROTHYMIDINE F 18; 9 [4 FLUORO 3 (HYDROXYMETHYL)BUTYL]GUANINE F 18; DENDRITIC CELL VACCINE; FLUORINE; INDIUM 111; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; CANCER IMMUNIZATION; CELL REGENERATION; CELL TRACKING; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CLINICAL PRACTICE; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC IMAGING; DRUG CYTOTOXICITY; DRUG HALF LIFE; EX VIVO STUDY; GLIOBLASTOMA; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; ISOTOPE LABELING; ISOTOPE TRACING; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DECAY; REVIEW; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION; TISSUE INJURY; TISSUE REGENERATION;

CELL TRANSPLANTATION; HUMANS; MOLECULAR IMAGING; REGENERATION; TISSUE THERAPY;

EID: 84870323734     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.106146     Document Type: Review

References (24)

1. Srinivas M, Aarntzen EH, Bulte JW, et al. Imaging of cellular therapies. Adv Drug Deliv Rev. 2010;62:1080-1093.
2. Gilad AA, Ziv K, McMahon MT, van Zijl PC, Neeman M, Bulte JW. MRI reporter genes. J Nucl Med. 2008;49:1905-1908.
3. McColgan P, Sharma P, Bentley P. Stem cell tracking in human trials: a meta-regression. Stem Cell Rev. 2011;7:1031-1040.
4. Lunn JS, Sakowski SA, Hur J, Feldman EL. Stem cell technology for neurodegenerative diseases. Ann Neurol. 2011;70:353-361.
5. Rasmussen TL, Raveendran G, Zhang J, Garry DJ. Getting to the heart of myocardial stem cells and cell therapy. Circulation. 2011;123:1771-1779.
6. Clifford DM, Fisher SA, Brunskill SJ, et al. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev. 2012;2:CD006536.
7. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007; 167:989-997. (Pubitemid 46835786)
8. Nguyen PK, Lan F, Wang Y, Wu JC. Imaging: guiding the clinical translation of cardiac stem cell therapy. Circ Res. 2011;109:962-979.
9. Kraitchman DL, Bulte JW. Imaging of stem cells using MRI. Basic Res Cardiol. 2008;103:105-113. (Pubitemid 351356753)
10. Yaghoubi SS, Campbell DO, Radu CG, Czernin J. Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications. Theranostics. 2012;2:374-391.
11. Andralojc K, Srinivas M, Brom M, et al. Obstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis. Diabetologia. 2012;55:1247-1257.
12. Saudek F, Jirak D, Girman P, et al. Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation. 2010;90:1602-1606.
13. Toso C, Vallee JP, Morel P, et al. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am J Transplant. 2008;8:701-706. (Pubitemid 351287550)
14. de Vries IJ, Lesterhuis WJ, Barentsz JO, et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol. 2005;23:1407-1413. (Pubitemid 41679393)
15. Karussis D, Karageorgiou C, Vaknin-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol. 2010;67:1187-1194.
16. Kedziorek DA, Muja N, Walczak P, et al. Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn Reson Med. 2010;63:1031-1043.
17. Srinivas M, Heerschap A, Ahrens ET, Figdor CG, de Vries IJ. 19F MRI for quantitative in vivo cell tracking. Trends Biotechnol. 2010;28:363-370.
18. Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol. 2012;12:269-281.
19. Verdijk P, Scheenen TW, Lesterhuis WJ, et al. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines. Int J Cancer. 2007;120:978-984. (Pubitemid 46214296)
20. 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content. Eur J Nucl Med Mol Imaging. 2003;30:440-447.
21. 18F]FDG labeling of neural stem cells for in vivo cell tracking with positron emission tomography: inhibition of tracer release by phloretin. Mol Imaging. 2012;11:1-12.
22. 18F]FLT) PET imaging. Proc Natl Acad Sci U S A. 2011;108:18396-18399.
23. Campbell DO, Yaghoubi SS, Su Y, et al. Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe. J Biol Chem. 2012;287:446-454.
24. Bulte JW. In vivo MRI cell tracking: clinical studies. AJR. 2009;193:314-325.